The aim is to evaluate the effectiveness of an AI-based device in detecting gastric neoplasms compared to standard methods.
Conducted a multicenter randomized controlled trial
Utilized AI technology for detecting gastric neoplasms
Compared detection rates between the AI device and standard practices
AI did not improve gastric neoplasm detection rates
Findings suggest limitations of AI in real-world clinical settings
Indicates need for additional studies to assess AI adaptability
Abstract
AI did not improve the detection rate of gastric neoplasms. Further real-world studies are needed to fully address the adaptability of AI. (Chinese Clinical Trial Registry, ChiCTR2100054449.).